Search Result "P38α"
Recent Developments of p38α MAP Kinase Inhibitors as Antiinflammatory Agents Based on the Imidazole Scaffolds
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 1 Year: 2013 Page: 1997-2016
Author(s): Ting-Ting Kong, Cheng-Mei Zhang, Zhao-Peng Liu
Rational Design of Novel Potential p38α MAPK Inhibitors with Drug-like Properties Using Pharmacophore and Similarity-based Virtual Screening Procedures
Journal: Current Bioactive Compounds
Volume: 9 Issue: 1 Year: 2013 Page: 3-13
Author(s): F. R. Pinsetta, C. A. Taft, C. H. T. P. Silva
(+)- and (-)-Itampolin A: First Total Synthesis, Anticancer Effect Through Inhibition of Phospho p38 Expression
Journal: Current Organic Synthesis
Volume: 14 Issue: 6 Year: 2017 Page: 912-917
Author(s): Jingwei Liang, Xinyang Li, Xin He, Qi Sun, Tingjian Zhang, Fanhao Meng
Anti-inflammatory Activities of Phenoxyphenyl Ureas Mediated by Inhibition of p38 Kinase
Journal: Current Enzyme Inhibition
Volume: 11 Issue: 2 Year: 2015 Page: 116-123
Author(s): Ravindra Kulkarni,Swapna Diwyani,Stefan Laufer,Chandrshekar V. M.,Achaiah G.,Prashant Gurav,Prasanna Habbu
Secondary Metabolites from Cissampelos, A Possible Source for New Leads with Anti-Inflammatory Activity
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 16 Year: 2017 Page: 1629-1644
Author(s): Mateus F. Alves,Marcus T. Scotti,Luciana Scotti,Francisco Jaime Bezerra Mendonça,José M. B. Filho,SÃlvia A. L. de Melo,Sócrates G. dos Santos,Margareth de F.F.M. Diniz
Privileged Scaffolds or Promiscuous Binders: A Glance of Pyrrolo[2,1-f][1,2,4]triazines and Related Bridgehead Nitrogen Heterocycles in Medicinal Chemistry
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 8 Year: 2013 Page: 1528-1548
Author(s): Yu'ning Song,Peng Zhan,Qingzhu Zhang,Xinyong Liu
IL-22 and Its Receptors, New Players in the Inflammatory Network
Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 5 Issue: 3 Year: 2006 Page: 251-257
Author(s): Laure Dumoutier, Jean-Christophe Renauld
Insight into the Structural Determinants of Imidazole Scaffold-Based Derivatives as P38 MAP Kinase Inhibitors by Computational Explorations
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 2 Year: 2012 Page: 4024-4037
Author(s): C. Huang, Y. Li, H. Ren, J. Wang, L. Shao, S. Zhang, G. Li, L. Yang
Novel Role of NPC1L1 in the Regulation of Hepatic Metabolism: Potential Contribution of Ezetimibe in NAFLD/NASH Treatment
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 1 Year: 2011 Page: 121-123
Author(s): Masayuki Yoshida
Tumor Necrosis Factor: Renaissance as a Cancer Therapeutic?
Journal: Current Cancer Drug Targets
Volume: 8 Issue: 2 Year: 2008 Page: 124-131
Author(s): D. Daniel, N. S. Wilson